Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up

J Antimicrob Chemother. 2017 Jul 1;72(7):2136-2138. doi: 10.1093/jac/dkx109.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • CD4 Lymphocyte Count
  • Cholesterol / blood
  • Female
  • Follow-Up Studies
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV Integrase Inhibitors / therapeutic use*
  • HIV-1 / genetics
  • Heterocyclic Compounds, 3-Ring / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Oxazines
  • Piperazines
  • Pyridones
  • RNA, Viral / blood
  • Triglycerides / blood
  • Viral Load / drug effects

Substances

  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • RNA, Viral
  • Triglycerides
  • Cholesterol
  • dolutegravir